Acknowledgements
We thank Dr. Thomas and Prof. Upadhyaya (Institute of Medical Genetics, Cardiff, United Kingdom), Prof. Yoshimura (Keio University, Japan), Prof. Scheffzek (Medical University of Innsbruck, Austria), Prof. Elgersma (Erasmus Medical Center, The Netherlands) and Prof. Zwartkruis (University of Utrecht, The Netherlands) for providing plasmid constructs. Jacqueline Boonman, Paul van den Berg, Astrid Dorhout, Femke Hendriks and Willemieke Nobel and Sandra van der Sluijs - de Heer are thanked for technical assistance and data curation. We thank Dr. van Dooren and Dr. van de Laar (Erasmus Medical Center, The Netherlands), Dr. Lesnik and Dr. Moghadasi (Leiden University Medical Center, The Netherlands), Dr. Sinnema (Maastricht University Medical Center, The Netherlands), Dr. Corsten (University Medical Center Groningen, The Netherlands), Dr. Plomp (Amsterdam University Medical Center, The Netherlands), Dr. Zekveld-Vroon (University Medical Center Utrecht, The Netherlands) and Dr. Spruijt (Radboud University Medical Center, The Netherlands) for providing patient samples and information.
This research is supported (not financially) by the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)—Project ID No 739547. ERN GENTURIS is partly co-funded by the European Union within the framework of the Third Health Programme “ERN-2016—Framework Partnership Agreement 2017–2021”.